Fig. 5: Immune Microenvironment Profiling and Immunotherapy Response Prediction Based on the Prognostic Model. | npj Precision Oncology

Fig. 5: Immune Microenvironment Profiling and Immunotherapy Response Prediction Based on the Prognostic Model.

From: G0S2: a potential target for NSCLC identified through prognostic models from multi-Omic analysis of regulatory T cell metabolic genes

Fig. 5

Expression differences of immune modulators between high and low risk score groups (A), and expression correlations between genes characterising risk scores and immune checkpoints (B). Results of GSEA KEGG analysis and GSEA GO analysis in the high-risk score group (C, D). Differences in predictors of immunotherapy response between high and low risk score groups (E-H). Relationship between risk scores and immunotherapy response in the GSE126044 dataset (I, J).

Back to article page